This project has been designed in order to contribute to the development of a novel technology consisting to use bacteriophage lytic enzymes as agents for controlling bacterial populations on human mucosal membranes. These tissues are the reservoir for man y pathogenic bacteria found in the environment (i.e., pneumococci, staphylococci, streptococci). In most instances, it is this mucosal reservoi ...